openPR Logo
Press release

Unveiling Dream Home: New Listing by Renowned Real Estate Expert Ron Galam

03-29-2024 10:38 PM CET | Industry, Real Estate & Construction

Press release from: ABNewswire

Unveiling Dream Home: New Listing by Renowned Real Estate Expert

Stunning 4-bed, 2-bath property hits the market! Meticulously crafted and move-in ready. Contact Ron Galam for details.
Los Angeles, CA - Nestled in the heart of a serene residential neighborhood, a meticulously crafted gated property is poised to captivate discerning homebuyers. Boasting 4 bedrooms, 2 baths, and a spacious 2-car garage with direct access to the house, this haven of tranquility offers ample space and comfort for modern living.

Image: https://www.abnewswire.com/uploads/18f0260e7e3e6ea895691e340467a3b2.png

Renowned real estate expert Ron Galam proudly presents this stunning property, which has undergone recent upgrades to enhance its allure and functionality. The remodeled kitchen and baths, completed in 2019, showcase the latest in contemporary design, while the installation of HVAC with central AC/heat ensures year-round comfort.

Step into the master bathroom and luxuriate in the rain shower, illuminated by recessed lighting that infuses the home with a warm and inviting ambiance. Recent improvements also include a brand-new shingle roof, fresh paint inside and out, and the added security of a wrought iron gated fence.

Beyond the meticulously maintained interior lies a backyard oasis, accessible through French doors, where outdoor gatherings are elevated by a built-in BBQ. Whether entertaining friends or enjoying quiet moments of solitude, this property offers the perfect setting for every occasion.

About Ron Galam:

Ron Galam's expertise in real estate stems from a lifelong dedication to service and integrity. Raised in a family with a strong commitment to law and justice, Ron's background as a Lieutenant in the IDF special forces instilled in him a deep sense of responsibility and leadership.

Following his military service, Ron pursued higher education in London, earning a BA and MBA in business administration. His passion for construction and design led him to establish his own construction company, specializing in custom homes and new construction projects.

In 2018, Ron facilitated his largest real estate transaction to date, managing several new construction projects in South America. With a black belt in full-contact karate and a commitment to healthy living, Ron brings discipline, resilience, and determination to every endeavor.

Now, Ron Galam invites you to explore this exceptional property, where meticulous craftsmanship meets modern elegance. With its pristine condition and move-in-ready status, it's the perfect opportunity to turn your dreams of homeownership into reality.

For more information about this property listing, please visit his website [https://www.rongalam.com/].

Media Contact
Company Name: Ron Galam Real Estate Group
Contact Person: Ron Galam EXP Realty Realtor, CA DRE# 01965466
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=unveiling-dream-home-new-listing-by-renowned-real-estate-expert-ron-galam]
Phone: +1 (310) 531-3381
Country: United States
Website: http://www.rongalam.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Unveiling Dream Home: New Listing by Renowned Real Estate Expert Ron Galam here

News-ID: 3446679 • Views:

More Releases from ABNewswire

Neuroendocrine Tumors Pipeline Assessment, 2024 Updates | In-depth Insights into Latest FDA, EMA, and PMDA Approvals, Clinical Trials, and Treatment Outlook | Pfizer, Takeda Oncology, Hutchison
Neuroendocrine Tumors Pipeline Assessment, 2024 Updates | In-depth Insights into …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Neuroendocrine Tumors pipeline constitutes 55+ key companies continuously working towards developing 60+ Neuroendocrine Tumors treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Neuroendocrine Tumors Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed
Rhinitis Pipeline and Clinical Trials Assessment 2024: FDA Approvals, Therapies and Key Companies involved by DelveInsight | Iltoo Pharma, Revolo Biotherapeutics, Anhui Palo Alto Pharma, Inmunotek SL
Rhinitis Pipeline and Clinical Trials Assessment 2024: FDA Approvals, Therapies …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Rhinitis pipeline constitutes 35+ key companies continuously working towards developing 35+ Rhinitis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Rhinitis Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
AAV in Gene Therapy Pipeline Drugs Analysis Report (2024 Updates): FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | Asklepios Biopharma, MeiraGTx, Gyroscope Therapeutics, Nanoscop
AAV in Gene Therapy Pipeline Drugs Analysis Report (2024 Updates): FDA Approvals …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, AAV in Gene Therapy pipeline constitutes 70+ key companies continuously working towards developing 235+ AAV in Gene Therapy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The AAV in Gene Therapy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed
Fuchs Dystrophy Pipeline Drugs Analysis Report, 2024: FDA Approvals, Clinical Trials, Therapies, MOA, ROA by DelveInsight | Design Therapeutics, Emmecell, Santen, Trefoil Therapeutics, Kowa Company
Fuchs Dystrophy Pipeline Drugs Analysis Report, 2024: FDA Approvals, Clinical Tr …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Fuchs Dystrophy pipeline constitutes 5+ key companies continuously working towards developing 5+ Fuchs Dystrophy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Fuchs Dystrophy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed

All 5 Releases


More Releases for Ron

Dr. Ron Wacker joins iComplai Advisory Board
iComplai, a Munich based regtech start-up for product safety, has just announced that Dr Ron Wacker has joined the team as advisor. Dr. Ron Wacker brings more than 12 years of experience in the area of food safety, with global leadership roles in worldwide testing companies like SGS and TÜV SÜD as well as manufacturers like Danone. Currently he is the director of Food and Feed Laboratories in South-West Europe at
Ron Bell’s New Sensation “Too Many People” Setting Flame
If you are a music enthusiast, you must be searching for some new music that can energize your inclination. However, you should tune in to new artist Ron Bell in soundcloud. His track “Too Many People" has assembled great number of remarks, plays and likes. Ron Bell anticipates that his music will get great acknowledgment before the worldwide audiences. "Too Many People" comes under storytelling music. As indicated by the
Keeping Ron "Forever Young"
"Uncle Ronny is a living legend of Texas music," says artrepreneur Nikki Young of her uncle, Ron Young. "And we want him to stay that way - a *living* legend - for as long as possible." In that spirit, nearly 300 of Ron Young's family, friends, and fans packed Sam's Burger Joint on Sunday, February 17 for "Forever Young," an all-day benefit for the singer/songwriter, who was diagnosed with an
Ron Baron's interest in Alternatives endorsed by AAA
High profile investor and member of the Forbes 400, Ron Baron, recently shared his fondness for alternative investments with journalists from Forbes, in an interview that has been welcomed by AAA. Boston, MA, January 25, 2013 - High profile investor and member of the Forbes 400, Ron Baron, recently shared his fondness for alternative investments with journalists from Forbes, in an interview that has been welcomed by Alternative Asset Analysis (AAA). Ron
06-25-2012 | Arts & Culture
Ron Young
New Music by Ron Young Is On The "Radar"
WHO: Ron Young WHAT: "Under the Texas Radar": CD Release Party WHEN: Sunday, July 8, 2012 6:00pm-9:00pm WHERE: Olmos Bharmacy 3902 McCullough Ave. San Antonio, TX 78212 Ron Young, a fixture in the Texas and Nashville music scenes, is bringing his music home to celebrate the release of his new CD. Young and his band, Young & Restless, will celebrate the debut of "Under the Texas Radar" with a special performance at Olmos Bharmacy on Sunday, July 8. The album
Rosendin Electric Names Ron Wilson New Director of Engineering
SAN JOSE, Calif. (March 1, 2011) – Rosendin Electric (rosendin.com), the nation’s largest private electrical contractor and a 100-percent employee-owned company, today announced the appointment of Ron Wilson to the newly created position of Director of Engineering. The appointment is part of an internal restructuring of Rosendin Electric’s Engineering group in order to meet customers’ expanding demands for their services, which now represents over $325 million per year in